Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Sun Pharmaceutical Industries Limited
Press Release Oct 16 2023
Business
Oct 16 2023
3 min read

Press Release Oct 16 2023

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 16, 2023, titled "Nidlegy Phase III PIVOTAL trial meets the study s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma".

View Attachment